
Group News
- Aspen announces local availability of Lilly’s Mounjaro
Aspen has announced the availability of Lilly's tirzepatide, marketed globally as Mounjaro®, a therapeutic option available to physicians for the treatment of Type II diabetes. The post Aspen […]
- Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
Aspen and SEMDSA earlier today raised awareness around the alarming rise of non-communicable diseases, particularly diabetes, in recognition of World Diabetes Day. The post Aspen and SEMDSA highlight […]
- Aspen to participate in the Investec CEO conference in London
Aspen's Stephen Saad and Sean Capazorio will take part in Investec's CEO conference in London from 14 to 15 November 2024. The post Aspen to participate in the Investec CEO conference in London […]
- Aspen partners with PinkDrive to mobilise cancer screening
Aspen has contributed towards the funding of a new mobile cancer screening clinic for rural and peri-urban disadvantaged communities. The post Aspen partners with PinkDrive to mobilise cancer […]
- Aspen’s revenue increases 10% underpinned by a strong second half performance
JSE-listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has reported solid Group financial results for the year ended 30 June 2024. The post […]